JP6785216B2 - 新規アレルゲン - Google Patents

新規アレルゲン Download PDF

Info

Publication number
JP6785216B2
JP6785216B2 JP2017503551A JP2017503551A JP6785216B2 JP 6785216 B2 JP6785216 B2 JP 6785216B2 JP 2017503551 A JP2017503551 A JP 2017503551A JP 2017503551 A JP2017503551 A JP 2017503551A JP 6785216 B2 JP6785216 B2 JP 6785216B2
Authority
JP
Japan
Prior art keywords
protein
sequence
equ
seq
ige
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017503551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017524358A (ja
JP2017524358A5 (enExample
Inventor
ラーシュ・マットソン
ウルリカ・オルソン
トーマス・ルンドグレン
ヨナス・リードホルム
ホーカン・ラーション
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Phadia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia AB filed Critical Phadia AB
Publication of JP2017524358A publication Critical patent/JP2017524358A/ja
Publication of JP2017524358A5 publication Critical patent/JP2017524358A5/ja
Application granted granted Critical
Publication of JP6785216B2 publication Critical patent/JP6785216B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2017503551A 2014-07-21 2015-07-20 新規アレルゲン Active JP6785216B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1450907-9 2014-07-21
SE1450907 2014-07-21
PCT/SE2015/050828 WO2016013971A1 (en) 2014-07-21 2015-07-20 Novel allergen

Publications (3)

Publication Number Publication Date
JP2017524358A JP2017524358A (ja) 2017-08-31
JP2017524358A5 JP2017524358A5 (enExample) 2018-08-16
JP6785216B2 true JP6785216B2 (ja) 2020-11-18

Family

ID=53872123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017503551A Active JP6785216B2 (ja) 2014-07-21 2015-07-20 新規アレルゲン

Country Status (10)

Country Link
US (1) US10753946B2 (enExample)
EP (1) EP3171890B1 (enExample)
JP (1) JP6785216B2 (enExample)
CN (1) CN106604929B (enExample)
AU (1) AU2015294723B2 (enExample)
CA (1) CA2955348A1 (enExample)
DK (1) DK3171890T3 (enExample)
ES (1) ES2856128T3 (enExample)
RU (1) RU2017104910A (enExample)
WO (1) WO2016013971A1 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019972A (en) * 1989-11-03 2000-02-01 Immulogic Pharmaceutical Corporation Peptides of human T cell reactive feline protein (TRFP)
EP1195606A1 (en) 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
WO2011133105A1 (en) * 2010-04-23 2011-10-27 Phadia Ab Novel allergen

Also Published As

Publication number Publication date
ES2856128T3 (es) 2021-09-27
CN106604929B (zh) 2021-11-05
WO2016013971A1 (en) 2016-01-28
EP3171890B1 (en) 2020-12-02
JP2017524358A (ja) 2017-08-31
AU2015294723B2 (en) 2021-05-06
CA2955348A1 (en) 2016-01-28
AU2015294723A1 (en) 2017-02-16
CN106604929A (zh) 2017-04-26
US10753946B2 (en) 2020-08-25
EP3171890A1 (en) 2017-05-31
RU2017104910A (ru) 2018-08-21
US20170219602A1 (en) 2017-08-03
DK3171890T3 (da) 2021-02-22

Similar Documents

Publication Publication Date Title
EP3467499A1 (en) Egg allergy antigen
CN110824156B (zh) 神经自身免疫疾病的诊断
Rihs et al. Recombinant Hev b 1: large‐scale production and immunological characterization
De Jong et al. Purification and characterization of naturally occurring post-translationally cleaved Ara h 6, an allergen that contributes substantially to the allergenic potency of peanut
JP7618641B2 (ja) 新規アレルゲン
JP6785216B2 (ja) 新規アレルゲン
González‐Rioja et al. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens
JP6280578B2 (ja) 新規のアレルゲン
RU2368620C2 (ru) ПРОИЗВОДНЫЕ PhI p 5а, ОБЛАДАЮЩИЕ СНИЖЕННОЙ АЛЛЕРГЕННОСТЬЮ И СОХРАНЕННОЙ Т-КЛЕТОЧНОЙ РЕАКТИВНОСТЬЮ
RU2592674C2 (ru) Аллергены, полученные рекомбинантными способами
WO2007103792A2 (en) Methods and compositions for diagnosis and immunotherapy of pollen allergy
CN114685636B (zh) 蒿属植物花粉过敏原、应用及试剂盒
EP2708555A2 (en) Polyclonal antibodies to cloned fungal polypeptide targets
KR102797285B1 (ko) 대두 알레르기의 항원
Mas García et al. A recombinant Sal k 1 isoform as an alternative to the polymorphic allergen from Salsola kali pollen for allergy diagnosis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180703

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180703

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190528

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190819

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191127

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200414

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200813

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200821

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200814

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200904

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201006

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201026

R150 Certificate of patent or registration of utility model

Ref document number: 6785216

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250